ADVERSE REACTIONS

To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689 or FDA at 1-800-332-1088 or www.fda.gov/medwatch.

"1-800-FDA-1088"

PRINCIPAL DISPLAY PANEL

NDC 0143-9141-01 Rx only

DOBUTamine
Injection, USP
250 mg per 20 mL (12.5 mg/mL)
For Intravenous Use ONLY
Must be diluted prior to use
Use within 24 hours after dilution
20 mL Single-Dose Vial

NDC 0143-9141-10 Rx only

DOBUTamine
Injection, USP
250 mg per 20 mL (12.5 mg/mL)
For Intravenous Use ONLY
Must be diluted prior to use
Use within 24 hours after dilution
10 x 20 mL Single-Dose Vials